dat.xu: A Network Meta-Analysis on Immune Checkpoint Inhibitor Drugs
In altmeta: Alternative Meta-Analysis Methods
dat.xu R Documentation
A Network Meta-Analysis on Immune Checkpoint Inhibitor Drugs
Description
This network meta-analysis investigates the effects of seven immune checkpoint inhibitor (ICI) drugs on all-grade treatment-related adverse events (TrAEs). It aimed to provide a safety ranking of the ICI drugs for the treatment of cancer.
Usage
data("dat.xu")
Format
A dataset of network meta-analysis with binary outcomes, containing 23 studies and 7 treatments.
sidstudy IDs.
tidtreatment IDs.
revent counts.
nsample sizes.
Details
Treatment IDs represent: 1) conventional therapy; 2) nivolumab; 3) pembrolizumab; 4) two ICIs; 5) ICI and conventional therapy; 6) atezolizumab; and 7) ipilimumab.
Source
Xu C, Chen YP, Du XJ, Liu JQ, Huang CL, Chen L, Zhou GQ, Li WF, Mao YP, Hsu C, Liu Q, Lin AH, Tang LL, Sun Y, Ma J (2018). "Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis." BMJ, 363, k4226. <doi: 10.1136/bmj.k4226>
altmeta documentation built on Aug. 29, 2022, 9:07 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| dat.xu | R Documentation |
A Network Meta-Analysis on Immune Checkpoint Inhibitor Drugs
Description
This network meta-analysis investigates the effects of seven immune checkpoint inhibitor (ICI) drugs on all-grade treatment-related adverse events (TrAEs). It aimed to provide a safety ranking of the ICI drugs for the treatment of cancer.
Usage
data("dat.xu")
Format
A dataset of network meta-analysis with binary outcomes, containing 23 studies and 7 treatments.
sidstudy IDs.
tidtreatment IDs.
revent counts.
nsample sizes.
Details
Treatment IDs represent: 1) conventional therapy; 2) nivolumab; 3) pembrolizumab; 4) two ICIs; 5) ICI and conventional therapy; 6) atezolizumab; and 7) ipilimumab.
Source
Xu C, Chen YP, Du XJ, Liu JQ, Huang CL, Chen L, Zhou GQ, Li WF, Mao YP, Hsu C, Liu Q, Lin AH, Tang LL, Sun Y, Ma J (2018). "Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis." BMJ, 363, k4226. <doi: 10.1136/bmj.k4226>
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.